Copyright
©The Author(s) 2016.
World J Hepatol. Jul 28, 2016; 8(21): 881-890
Published online Jul 28, 2016. doi: 10.4254/wjh.v8.i21.881
Published online Jul 28, 2016. doi: 10.4254/wjh.v8.i21.881
Ref. | Year | No. of patients | Study design | Criteria | AFP cut-off values |
Yang et al[56] | 2007 | 63 | Retrospective | AFP | 20 ng/mL, 200 ng/mL, 1000 ng/mL |
Tumor size | |||||
Number of tumors | |||||
Zheng et al[63] | 2008 | 195 | Retrospective | AFP | 400 ng/mL |
Total tumor diameter | |||||
Histopathologic grade | |||||
Lai et al[64] | 2012 | 158 | Retrospective | AFP | 400 ng/mL |
Total tumor diameter | |||||
Duvoux et al[57] | 2012 | 435 | Prospective | AFP | 100 ng/mL, 1000 ng/mL |
Tumor size | |||||
Number of tumors | |||||
Kashkoush et al[76] | 2014 | 115 | Retrospective | AFP | 400 ng/mL |
Actual tumor volume | |||||
Toso et al[75] | 2015 | 233 | Prospective | AFP | 400 ng/mL |
Total tumor volume | |||||
Hong et al[77] | 2015 | 123 | Retrospective | AFP | 200 ng/mL |
F-FDG PET positivity |
- Citation: Charrière B, Maulat C, Suc B, Muscari F. Contribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinoma. World J Hepatol 2016; 8(21): 881-890
- URL: https://www.wjgnet.com/1948-5182/full/v8/i21/881.htm
- DOI: https://dx.doi.org/10.4254/wjh.v8.i21.881